Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -7.42%911.25M | ---- | 29.36%984.33M | ---- | 69.42%760.92M | ---- | 31.55%449.14M | ---- | 100.48%341.43M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -0.37%-59.99M | ---- | -291.67%-59.77M | ---- | -618.75%-15.26M | ---- | -27.43%-2.12M | ---- | 58.91%-1.67M |
| Attributable subsidiary (profit) loss | ---- | -93.77%491K | ---- | 66.81%7.88M | ---- | 14,665.63%4.73M | ---- | --32K | ---- | ---- |
| Revaluation surplus: | ---- | -4.87%-10.92M | ---- | -168.81%-10.41M | ---- | 422.85%15.13M | ---- | -52.37%-4.69M | ---- | 61.56%-3.08M |
| -Other fair value changes | ---- | -4.87%-10.92M | ---- | -168.81%-10.41M | ---- | 422.85%15.13M | ---- | -52.37%-4.69M | ---- | 61.56%-3.08M |
| Asset sale loss (gain): | ---- | 46.68%553K | ---- | -65.82%377K | ---- | 80.82%1.1M | ---- | -1.61%610K | ---- | -45.85%620K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 46.68%553K | ---- | -65.82%377K | ---- | 80.82%1.1M | ---- | -1.61%610K | ---- | -45.85%620K |
| Depreciation and amortization: | ---- | 33.93%194.79M | ---- | 27.79%145.44M | ---- | 22.36%113.81M | ---- | 21.32%93.01M | ---- | -7.31%76.67M |
| -Amortization of intangible assets | ---- | 22.65%21.3M | ---- | 12.99%17.37M | ---- | 12.45%15.37M | ---- | 123.17%13.67M | ---- | 29.44%6.13M |
| Financial expense | ---- | -21.39%10.45M | ---- | -16.68%13.29M | ---- | -30.02%15.95M | ---- | 83.00%22.79M | ---- | 79.69%12.46M |
| Exchange Loss (gain) | ---- | -1,553.26%-4.81M | ---- | 93.73%-291K | ---- | -111.85%-4.64M | ---- | 94.27%39.17M | ---- | 152.90%20.16M |
| Special items | ---- | -33.64%60.84M | ---- | -34.22%91.69M | ---- | 106.34%139.39M | ---- | 83.39%67.55M | ---- | --36.84M |
| Operating profit before the change of operating capital | ---- | -5.96%1.1B | ---- | 13.71%1.17B | ---- | 54.94%1.03B | ---- | 37.66%665.5M | ---- | 88.09%483.43M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 142.87%1B | ---- | 141.99%413.26M | ---- | -131.24%-984.1M | ---- | -229.58%-425.56M | ---- | 180.33%328.42M |
| Accounts receivable (increase)decrease | ---- | 142.42%144.44M | ---- | -23.46%-340.51M | ---- | 30.43%-275.81M | ---- | -6,579.13%-396.46M | ---- | -88.00%6.12M |
| Accounts payable increase (decrease) | ---- | -530.84%-158.42M | ---- | -93.74%36.77M | ---- | 63.58%587.36M | ---- | 337.78%359.06M | ---- | -224.83%-151M |
| Cash from business operations | 8.16%470.81M | 63.20%2.09B | -15.81%435.29M | 257.53%1.28B | -3.13%517.01M | 77.04%358.59M | 345.60%533.71M | -69.63%202.54M | -29.47%119.77M | 198.86%666.97M |
| Other taxs | -3.27%-125.08M | ---- | -95.63%-121.11M | ---- | -50.74%-61.91M | ---- | -208.60%-41.07M | ---- | 31.86%-13.31M | ---- |
| Special items of business | ---- | -53.88%-939.88M | ---- | -216.61%-610.79M | ---- | -46.14%523.79M | ---- | 290.20%972.53M | ---- | ---511.31M |
| Net cash from operations | 10.04%345.73M | 71.69%1.15B | -30.97%314.18M | -23.92%671.28M | -7.62%455.11M | -24.91%882.37M | 362.73%492.65M | 654.92%1.18B | -29.16%106.47M | -24.42%155.65M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 50.85%38.76M | 0.37%59.99M | 18.82%25.7M | 291.67%59.77M | 627.66%21.63M | 618.75%15.26M | 696.78%2.97M | 23.22%2.12M | -69.12%373K | -57.55%1.72M |
| Decrease in deposits (increase) | --65.42M | ---170.68M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Sale of fixed assets | ---- | ---- | ---- | ---- | ---- | 37.24%1.12M | -49.10%197K | 48.10%819K | 66.09%387K | -97.22%553K |
| Purchase of fixed assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 6.80%-129.75M |
| Selling intangible assets | -50.08%314K | -61.30%1.02M | 1,472.50%629K | --2.62M | --40K | ---- | ---- | ---- | ---- | ---- |
| Acquisition of subsidiaries | ---- | --121.56M | --121.56M | ---- | ---- | ---1.07M | ---8.19M | ---- | ---- | ---- |
| Recovery of cash from investments | 19.30%3.69M | -1.20%9.89M | -20.85%3.09M | 104.10%10.01M | --3.91M | ---244.17M | ---- | ---- | -25.84%1.15M | --8.83M |
| Cash on investment | 33.81%-427.53M | 35.86%-433.12M | -32.97%-645.89M | 24.72%-675.28M | 22.08%-485.74M | -97.43%-897.07M | -199.14%-623.38M | ---454.37M | -246.71%-208.39M | ---- |
| Other items in the investment business | ---- | -281.96%-354.37M | ---- | --194.75M | ---- | ---- | ---- | 119.26%3.3M | ---- | -74.06%-17.13M |
| Net cash from investment operations | 35.48%-319.33M | -87.62%-765.72M | -7.55%-494.91M | 63.75%-408.13M | 26.77%-460.17M | -151.25%-1.13B | -204.34%-628.4M | -230.07%-448.13M | -261.52%-206.48M | 35.90%-135.77M |
| Net cash before financing | 114.61%26.4M | 46.98%386.77M | -3,468.98%-180.73M | 208.04%263.15M | 96.27%-5.06M | -133.50%-243.56M | -35.73%-135.76M | 3,555.88%726.94M | -207.35%-100.02M | 438.57%19.88M |
| Cash flow from financing activities | ||||||||||
| New borrowing | --50M | -82.89%17.62M | ---- | -76.10%103M | -67.21%26.64M | -10.66%430.92M | -40.85%81.24M | -27.57%482.33M | -77.47%137.33M | 830.34%665.93M |
| Refund | 41.79%-49.18M | 8.26%-165.13M | -20.87%-84.49M | 50.48%-180M | -179.60%-69.9M | 34.40%-363.48M | ---25M | 18.80%-554.07M | ---- | -516.87%-682.33M |
| Issuing shares | ---- | -100.00%1K | ---- | 60,126,200.00%601.26M | --567.21M | -100.00%1K | ---- | --571.6M | --493.98M | ---- |
| Interest paid - financing | -11.32%-4.71M | 19.64%-11.43M | 60.17%-4.23M | -7.41%-14.22M | -33.97%-10.62M | 41.90%-13.24M | 31.52%-7.93M | -83.00%-22.79M | -204.07%-11.58M | -79.69%-12.46M |
| Dividends paid - financing | ---- | ---110.81M | ---- | ---- | ---- | ---- | ---- | ---30M | ---30M | ---- |
| Issuance expenses and redemption of securities expenses | ---- | ---15.22M | ---7.54M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other items of the financing business | -38.40%36.49M | 4,509.23%153.86M | 58.42%59.24M | -66.62%3.34M | --37.39M | --10M | ---- | ---- | ---- | ---- |
| Net cash from financing operations | 138.92%16.53M | -128.41%-144.06M | -107.76%-42.47M | 788.65%506.98M | 1,116.35%547.65M | -87.18%57.05M | -92.33%45.02M | 1,553.98%444.99M | 8,486.53%587.15M | 56.22%-30.61M |
| Effect of rate | 285.62%11.61M | -52.60%13.37M | -132.32%-6.26M | 253.01%28.2M | -23.78%19.36M | 115.92%7.99M | 332.56%25.4M | -208.77%-50.17M | -294.32%-10.92M | -415.45%-16.25M |
| Net Cash | 119.23%42.93M | -68.48%242.71M | -141.14%-223.21M | 512.92%770.12M | 698.00%542.59M | -115.91%-186.51M | -118.63%-90.73M | 11,031.13%1.17B | 387.09%487.13M | 85.85%-10.72M |
| Begining period cash | 11.81%2.42B | 58.26%2.17B | 58.26%2.17B | -11.53%1.37B | -11.53%1.37B | 262.63%1.55B | 262.63%1.55B | -5.38%427.12M | -5.38%427.12M | -13.53%451.4M |
| Cash at the end | 27.85%2.48B | 11.81%2.42B | 0.36%1.94B | 58.26%2.17B | 30.25%1.93B | -11.53%1.37B | 64.23%1.48B | 264.93%1.55B | 62.17%903.33M | -5.97%424.43M |
| Cash balance analysis | ||||||||||
| Cash and bank balance | ---- | -8.21%1.48B | ---- | --1.61B | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash and cash equivalent balance | ---- | -8.21%1.48B | ---- | --1.61B | ---- | ---- | ---- | ---- | ---- | ---- |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.